December 19, 2024 - 18:45

BOSTON & MONTREAL, December 19, 2024—enGene Holdings Inc., a clinical-stage genetic medicines company, has released its financial results for the full year 2024 alongside significant business updates. The company is advancing its lead investigational product, detalimogene voraplasmid, which is currently undergoing a pivotal study targeting patients with high-risk, Bacillus Calmette-Guérin (BCG)-unresponsive, non-muscle invasive bladder cancer (NMIBC) characterized by carcinoma in situ (CIS).
The financial report highlighted the company’s strategic investments in research and development, aimed at enhancing the efficacy of its therapeutic offerings. enGene's commitment to innovation in genetic medicine is evident as it continues to focus on pivotal clinical trials that could potentially transform treatment options for patients suffering from challenging forms of cancer.
In addition to its financial performance, enGene emphasized its ongoing efforts to strengthen partnerships and collaborations that will facilitate the advancement of its pipeline. The company remains optimistic about its future prospects and the potential impact of its therapies on patient outcomes.
November 19, 2026 - 06:01
Update on Portland's Downtown: Visitor Growth Amid Job LossesPortland`s downtown is seeing an increase in visitors, with an impressive 32 million pedestrian visits recorded in 2025. This marks a 5.5 percent rise, the highest in five years. However, this...
November 18, 2026 - 09:38
Robert Pattinson Takes on the Role of James Bond: A New Era of LuxuryIn a surprising turn of events, Robert Pattinson has been cast as the next James Bond, sparking excitement and speculation among fans and critics alike. Known for his versatility as an actor,...
November 17, 2026 - 20:00
Recovery Centers of America Shuts Down Major Treatment FacilityRecovery Centers of America will close its 133-bed residential treatment facility in Mays Landing, New Jersey, marking the end of an era for the location that had seen significant growth over the...
November 17, 2026 - 00:18
Microsoft Identifies Software Bug Causing Major Outlook and Microsoft 365 DisruptionMicrosoft has disclosed that a software bug, which was inadvertently introduced in July, caused significant disruptions for users of Outlook and Microsoft 365. This glitch went undetected during...